ReviewAntioxidants (Basel, Switzerland)2023

Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects.

Pasquale Pagliaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.